Loading company…
Won 4 federal SBIR/STTR research awards from HHS and other federal agencies.
Marker Therapeutics, Inc. has been awarded 4 US Small Business Innovation Research (SBIR/STTR) contracts totalling $6,672,209 between 2023 and 2024. These are non-dilutive federal research grants, not equity financing. The company is based in Houston, Texas.
No investors recorded yet for Marker Therapeutics, Inc..
Add an investorMarker Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Marker Therapeutics, Inc..
Add diversity data